Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4.03% is 78% above its 5-year average of -18.71%, near the high end of its 5-year range (-103.90%–2.10%).
7.52% below its 12-month average of -3.75%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.10%.
NET PROFIT MARGIN
-4.03%
NET PROFIT MARGIN AVG TTM
-3.75%
NET PROFIT MARGIN AVG 3Y
-13.22%
NET PROFIT MARGIN AVG 5Y
-18.71%
NET PROFIT MARGIN AVG 10Y
-9.72%
NET PROFIT MARGIN AVG 15Y
-3.95%
NET PROFIT MARGIN AVG 20Y
-1.65%
CURRENT VS TTM AVG
-7.52%
CURRENT VS 3Y AVG
+69.53%
CURRENT VS 5Y AVG
+78.46%
CURRENT VS 10Y AVG
+58.56%
CURRENT VS 15Y AVG
-2.06%
CURRENT VS 20Y AVG
-144.51%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1450.00%
vs the sector median at left
KORU Medical Systems, Inc.
Market Cap
$137.80M
Net Profit Margin
-4.03%
TTM Avg
-3.75%
3Y Avg
-13.22%
5Y Avg
-18.71%
Market Cap
$136.67M
Net Profit Margin
-396.52%
TTM Avg
-411.88%
3Y Avg
-411.88%
5Y Avg
-411.88%
Market Cap
$136.57M
Net Profit Margin
27.54%
TTM Avg
-18.99%
3Y Avg
-63.93%
5Y Avg
-73.34%
Market Cap
$139.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3984.32%
5Y Avg
-3047.80%
Market Cap
$139.47M
Net Profit Margin
-153.61%
TTM Avg
-101.12%
3Y Avg
-50.56%
5Y Avg
-33.71%
Market Cap
$139.84M
Net Profit Margin
-395.25%
TTM Avg
-276.53%
3Y Avg
-199.61%
5Y Avg
-174.03%
Market Cap
$143.10M
Net Profit Margin
-435.70%
TTM Avg
-1104.64%
3Y Avg
-1053.90%
5Y Avg
-4200.61%
Market Cap
$132.03M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $137.80M | -4.03% | -3.75% | -13.22% | -18.71% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | -396.52% | -411.88% | -411.88% | -411.88% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 27.54% | -18.99% | -63.93% | -73.34% |
| Immuneering Corporation (IMRX)vs › | $139.04M | 0.00% | 0.00% | -3984.32% | -3047.80% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -153.61% | -101.12% | -50.56% | -33.71% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | -395.25% | -276.53% | -199.61% | -174.03% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -435.70% | -1104.64% | -1053.90% | -4200.61% |
| LifeMD, Inc. (LFMD)vs › | $132.03M | -10.40% | -6.28% | -16.07% | -47.85% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-3.7%
Net Profit Margin
-4.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 2.10% |
| 2026-03-31 | -6.86% |
| 2025-12-31 | -4.47% |
| 2025-09-30 | -7.48% |
| 2025-06-30 | -2.03% |
| 2025-03-31 | -12.10% |
| 2024-12-31 | -17.66% |
| 2024-09-30 | -19.33% |
| 2024-06-30 | -11.73% |
| 2024-03-31 | -23.62% |
| 2023-12-31 | -103.90% |
| 2023-09-30 | -19.54% |
| 2023-06-30 | -35.98% |
| 2023-03-31 | -32.61% |
| 2022-12-31 | -26.91% |
| 2022-09-30 | -15.79% |
| 2022-06-30 | -44.62% |
| 2022-03-31 | -40.64% |
| 2021-12-31 | -16.46% |
| 2021-09-30 | -18.11% |
| 2021-06-30 | -20.34% |
| 2021-03-31 | -23.50% |
| 2020-12-31 | -20.57% |
| 2020-09-30 | 4.10% |
| 2020-06-30 | -13.96% |
| 2020-03-31 | 7.10% |
| 2019-12-31 | -1.29% |
| 2019-09-30 | 9.85% |
| 2019-06-30 | 1.46% |
| 2019-03-31 | -1.72% |
| 2018-12-31 | -8.31% |
| 2018-09-30 | 8.50% |
| 2018-06-30 | 10.57% |
| 2018-03-31 | 10.00% |
| 2017-12-31 | 11.69% |
| 2017-09-30 | 6.90% |
| 2017-06-30 | 3.88% |
| 2017-02-28 | -3.88% |
| 2016-11-30 | -3.27% |
| 2016-08-31 | -2.62% |
| 2016-05-31 | -7.80% |
| 2016-02-29 | 10.43% |
| 2015-11-30 | 5.33% |
| 2015-08-31 | 10.59% |
| 2015-05-31 | -2.46% |
| 2015-02-28 | 8.68% |
| 2014-11-30 | 3.49% |
| 2014-08-31 | 8.10% |
| 2014-05-31 | 5.99% |
| 2014-02-28 | 14.33% |
| 2013-11-30 | 7.43% |
| 2013-08-31 | 4.52% |
| 2013-05-31 | 3.91% |
| 2013-02-28 | 11.48% |
| 2012-11-30 | 2.68% |
| 2012-08-31 | 17.97% |
| 2012-05-31 | 5.18% |
| 2012-02-29 | 15.62% |
| 2011-11-30 | 12.14% |
| 2011-08-31 | 8.67% |
| 2011-05-31 | 13.25% |
| 2011-02-28 | 21.59% |
| 2010-11-30 | 13.41% |
| 2010-08-31 | 9.38% |
| 2010-05-31 | 9.00% |
| 2010-02-28 | 59.05% |
| 2009-11-30 | 6.18% |
| 2009-08-31 | 11.68% |
| 2009-05-31 | 7.88% |
| 2009-02-28 | 52.20% |
| 2008-11-30 | 22.41% |
| 2008-08-31 | 29.85% |
| 2008-05-31 | 9.26% |
| 2008-02-29 | 8.75% |
| 2007-11-30 | 9.88% |
| 2007-08-31 | 8.97% |
| 2007-05-31 | -44.92% |
| 2007-02-28 | 5.73% |
| 2006-11-30 | -14.78% |
| 2006-08-31 | -21.43% |
| 2006-05-31 | -59.62% |
| 2006-02-28 | -23.58% |
| 2005-11-30 | 13.33% |
| 2005-08-31 | -10.55% |
| 2005-05-31 | -38.17% |
| 2005-02-28 | -53.87% |
| 2004-11-30 | -36.06% |
| 2004-08-31 | -25.18% |
| 2004-05-31 | 0.21% |
| 2004-02-29 | -30.00% |
| 2003-11-30 | -19.97% |
| 2003-08-31 | -18.83% |
| 2003-05-31 | -6.73% |
| 2003-02-28 | -42.65% |
| 2002-11-30 | -7.71% |
| 2002-08-31 | -3.96% |
